“Fauci said patients taking the drug usually took 11 days to recover, compared to 15 days in the placebo group. He said the mortality benefit of remdesivir “has not yet reached statistical significance.”
As flagged earlier, Gilead said those tests showed that half the severely ill patients treated with remdesivir recovered and were released from hospital within two weeks.
Dr. Fauci says early results of Gilead's coronavirus drug trial shows significant positive effect, suggests "a drug can block this virus" pic.twitter.com/kBnkAo76el
Treating coronavirus patients with the antiviral drug remdesivir showed no “significant clinical benefits” in the first randomised trial of its kind, according to research released on Wednesday, AFP reports.
In a study among more than 200 Covid-19 patients in Wuhan, China, published in The Lancet, doctors found no positive effects of administering the drug compared with a control group of adults.
Bloomberg’s John Authers has an interesting theory about the market rally.
He suspects that investors are piling back into riskier assets because they’re less worried that they’ll catch Covid-19 themselves, rather than really thinking about the wider economic damage being caused.
He writes:
The rest of the week will have plenty of earnings announcements and central bank meetings to give rational reasons to buy or sell the market. Beyond that, the reduction in personal fear of the virus, and the unquestionable successes in holding it back, may have led to an irrational reduction in estimates of the economic damage.
I fear that the market rally has been driven by people for whom the virus seems less immediate and close, and who have moved from excessive fear to over-optimistic forecasts that the disease will now disappear.
In these extraordinary times, the Guardian’s editorial independence has never been more important. Because no one sets our agenda, or edits our editor, we can keep delivering quality, trustworthy, fact-checked journalism each and every day. Free from commercial or political bias, we can report fearlessly on world events and challenge those in power.
Your support protects the Guardian’s independence. We believe every one of us deserves equal access to accurate news and calm explanation. No matter how unpredictable the future feels, we will remain with you, delivering high quality news so we can all make critical decisions about our lives, health and security – based on fact, not fiction.
Fauci said he was told data from the trial showed a “clear cut positive effect in diminishing time to recover.”
Fauci said patients taking the drug usually took 11 days to recover, compared to 15 days in the placebo group. He said the mortality benefit of remdesivir “has not yet reached statistical significance.”
As flagged earlier, Gilead said those tests showed that half the severely ill patients treated with remdesivir recovered and were released from hospital within two weeks.
Dr. Fauci says early results of Gilead’s coronavirus drug trial shows significant positive effect, suggests “a drug can block this virus”
However…. according to the AFP newswire, another test has not gone so well.
Treating coronavirus patients with the antiviral drug remdesivir showed no “significant clinical benefits” in the first randomised trial of its kind, according to research released on Wednesday, AFP reports.
In a study among more than 200 Covid-19 patients in Wuhan, China, published in The Lancet, doctors found no positive effects of administering the drug compared with a control group of adults.
Bloomberg’s John Authers has an interesting theory about the market rally.
He suspects that investors are piling back into riskier assets because they’re less worried that they’ll catch Covid-19 themselves, rather than really thinking about the wider economic damage being caused.
He writes:
The rest of the week will have plenty of earnings announcements and central bank meetings to give rational reasons to buy or sell the market. Beyond that, the reduction in personal fear of the virus, and the unquestionable successes in holding it back, may have led to an irrational reduction in estimates of the economic damage.
I fear that the market rally has been driven by people for whom the virus seems less immediate and close, and who have moved from excessive fear to over-optimistic forecasts that the disease will now disappear.
In these extraordinary times, the Guardian’s editorial independence has never been more important. Because no one sets our agenda, or edits our editor, we can keep delivering quality, trustworthy, fact-checked journalism each and every day. Free from commercial or political bias, we can report fearlessly on world events and challenge those in power.
Your support protects the Guardian’s independence. We believe every one of us deserves equal access to accurate news and calm explanation. No matter how unpredictable the future feels, we will remain with you, delivering high quality news so we can all make critical decisions about our lives, health and security – based on fact, not fiction.
UK pub chain Wetherspoons has told the City tonight that it expects to keep its pubs closed until late June.
It made the prediction as it announced a new equity placing to raise £140m, to tide it through the lockdown.
Wetherspoons argued that it is relatively well-placed to handle social distancing rules, once restrictions are eased.
The company is likely to make some changes to its operating model, assuming increased social distancing, and anticipates a gradual recovery in customer numbers.
Wetherspoon pubs are substantially larger than average, and most have outside facilities. The company believes these factors are likely to assist if social distancing measures apply.
However… the government hasn’t yet said when it will start to lift the current lockdown, and many analysts suspect pubs will not be the first places to reopen either.
While the govt refuse to discuss when and how a lockdown might happen, businesses are making their own plans
Wetherspoon's are planning to reopen their pubs and hotels 'in or around June'
Empty Air France and Delta Airlines check-in desks at Paris-Charles-de-Gaulle airport last month. Photograph: Bertrand Guay/AFP via Getty Images
A dozen European Union member states have called for a relaxation of air-passenger rights rules to help airlines deal with the economic fallout from coronavirus.
France, Poland, the Netherlands and Ireland are among the 12 countries who have proposed amending EU rules, so airlines can reimburse cancelled tickets with vouchers, rather than cash.
Air-France/KLM and Lufthansa are currently negotiating government bailouts, while British Airways has announced plans to make 12,000 employees redundant, as the virus has brought international travel to a near standstill, leaving planes grounded.
The 12 member states argue the requirement of a 2004 EU regulation to reimburse cancelled flights in cash is adding to airlines’ cash-flow problems.
The joint statement calls on the European commission, which oversees EU law, to urgently amend the law, declaring:
The goal shared by the European Union and its member states must now be to preserve the structure of the European air traffic market beyond the current crisis, while considering the interests and necessary protection of passengers.
The EU’s 27 transport ministers are holding a conference call to discuss an exit from current restrictions. So far the commission has declined to say publicly whether it backs the voucher plan.
European commission vice president Vĕra Jourová told reporters earlier today.
“The debate is ongoing so I am not now giving you the final word,”
But her colleague in charge of transport, Adina Vălean, has previously said airlines can only offer vouchers if passengers can accept them.
Ministers are also looking at what green strings should be attached to airline bailouts. France’s transport minister Élisabeth Borne has said government aid for Air France would be linked to cutting pollution, including a 50% reduction in CO2 emissions by 2024 for domestic flights and fleet renewal to cut total emissions.
Joanna Partridge
The markets may be flying today, but the long-term cost of the pandemic will be very large…. something that is worrying politicians.
Mel Stride, the Conservative MP who chairs parliament’s influential Treasury Select Committee, has warned today that there needs to be debate about who should bear the heaviest levels of additional taxation to support the economy, once the country emerges from lockdown.
Stride told the BBC’s Radio 4 that:
“The public finances will clearly be under significantly more pressure because there will be more debt that the economy is having to service and bear, there will be very difficult choices there around spending on the one hand and taxation on the other,”
Stride added that often younger people and the lowest paid have been most impacted by the disruption caused by the coronavirus crisis.
FTSE 100 up 20% from March lows
Today’s rally means the FTSE 100 has surged by over 20% since March 23, when it closed at just 4993 points.
That means the blue-chip index is back in Bull Market territory (defined as a fifth above a recent low).
That’s a relief to large and small investors alike (anyone saving for a pension has been hit by this year’s slump). But the FTSE 100 is still down 18% so far this year, so maybe hold back on the bunting….
Back on Wall Street, the Dow is up 2.3% or 549 points higher at 24,651 points.
Boeing is the top riser, up 8%, after it revealed plans to cut 10% of its workforce (see earlier post)
American Express and VISA are also leading the risers, up 5%, on hopes that consumer spending may recover soon if lockdown rules are eased.
FTSE 100 jumps to seven-week high
Newsflash: Britain’s FTSE 100 has closed at a new seven-week high, lifted by optimism that the worst of the coronavirus crisis could be behind us soon.
The blue-chip index has ended the day up 156 points, or 2.6%, at 6115 points.
That’s its highest level since Tuesday 10th March (the day after Crash Monday), and the biggest one-day rise since 17th April.
Many recently-unloved stocks had a very strong day, with cruise operator Carnival jumping 16%, energy supplier Centrica gaining 15%, and budget airline easyJet up 12%.
European markets also rallied hard, with Germany’s DAX up almost 3%.
European stock markets higher as traders are optimistic that lockdowns could be loosened. Some countries have reopened small parts of their respective economies, and there is a general feeling in the markets that we are likely to see more of this in the months ahead. Traders are also bullish on stocks due to a report that showed some progress had been made in relation to a possible treatment for Covid-19.
It is understood that Gilead Science’s antiviral drug, Remdesivir, showed ‘positive data’ in a trail. There has been some back and forth in relation to the drug in question, but for now the sentiment seems to be positive. The FTSE 100 and the DAX 30 both hit levels last seen in early March.
Oil is rallying hard, after the latest inventory figures showed a smaller rise in crude stocks than expected.
US crude oil inventories rose by 9 million barrels in the week to 24 April, the Energy Information Administration reports. Economists had expected a 10.6m rise.
Gasoline stocks fell by 3.7m barrels, against forecasts of a 2.5m rise.
This appears to be calming concerns that producers are running out of places to store energy stocks.
In response, a barrel of US crude for June delivery now costs $16.26 per barrel – up $4, or 32%, today.
For the week ending April 24th 2020, US commercial crude oil inventory rose by 10.136 million barrels but 1.148 million were transferred to the Strategic Petroleum Reserves, so the net effect is a build of 8.988 million.